Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

NCT00981747 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Funding was withdrawn.

Conditions

Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis

Interventions

DRUG: Sildenafil
DRUG: Losartan
DRUG: Sildenafil and Losartan
DRUG: Placebo Oral Tablet

Sponsor

Alicia Gerke

Collaborators

[object Object]